Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours (REVASCAT)

This study has been terminated.
(Following DSMB advice after first interim analysis (n=174))
Sponsor:
Collaborator:
Medtronic - MITG
Information provided by (Responsible Party):
Fundacio Ictus Malaltia Vascular
ClinicalTrials.gov Identifier:
NCT01692379
First received: September 20, 2012
Last updated: December 15, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
No publications provided by Fundacio Ictus Malaltia Vascular

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):